Eczema Patients Have Lost Faith In Treatment: Survey
"); jQuery("#212 h3").html("

"); });
2022-09-13 HKT 20:53
A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.
GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.
Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.
He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.
“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.
“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.
“Public doctors have a limited time to see a lot of patients every day."
But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”
Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.
Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.
“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.
“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”
To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.
Visa Enables Apple Pay For Chinese Cardholders Overseas
Visa announced that it will support Chinese-issued Visa cards on Apple Pay for use at overseas Visa-accepting merchants... Read more
WeLab Raises US$220M In Series D Financing
WeLab has closed a US$220 million Series D strategic financing round, comprising a mix of debt and equity. The raise is... Read more
Why Cross Border Payments Fail SMEs And How XTransfer Fixes It
Digital banking in Asia was supposed to change the world. Five years later, did it live up to the hype? In this in-dept... Read more
Sony And Bolttech Launch My Sony Care+ In HK
Japanese electronics group Sony has partnered with insurtech company bolttech to launch My Sony Care+, an embedded prot... Read more
Hong Kong Hosts 19th Asian Financial Forum On 26-27 January
The Hong Kong Government and the Hong Kong Trade Development Council (HKTDC) will co-organise the 19th Asian Financial ... Read more
South Korea Plans Stablecoin Rules And Digital Asset ETFs In 2026
The South Korean government plans to introduce a second-phase digital asset bill this year, which will establish a regu... Read more